IMS Canada

What's New

IMS Canada Recognizes Quebec Health Professionals for their Contribution to the Appropriate Use of Medicines
IMS Health Reports Retail Prescription Volume Grew 7.1 Percent in 2008
Canada’s Rx Atlas gives a comprehensive portrait of nearly $20 billion spent on pharmaceuticals in Canada.
IMS Health Forecasts 4.5 – 5.5 Percent Growth for Global Pharmaceutical Market in 2009, Exceeding $820 Billion

Physician’s role in drug selection continues to decline - Ongoing shift in influence towards drug plan managers, new prescribers and consumers
Canadian Prescription Drug Sales Experience Slowest Growth in a Decade with 6.3 Percent Increase. Growth of brand-name companies hit by all-time high value of patent expiries in 2007
CompuScript, the country’s gold standard in measuring Canadian prescription activity, helps researchers understand drug utilization in Canada
"Stimulant Use in New Brunswick", a poster authored by IMS, was presented at the 2007 CADTH Invitational Symposium – Informing Policy, Influencing Practice, Improving Health, held in April 2007 in Ottawa.

Change Language:

Select One

CLIENT LOGIN & SUPPORT